LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) announces that on September 13, 2024, the Office of the United States Trade Representative (“USTR”) revealed final adjustments to tariffs placed on Chinese imported syringes and needles. Despite initially proposing a 50% rate, the USTR set the tariff at 100%

LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $6.0 million for the second quarter of 2024 and an operating loss of $5.8 million for the period, as compared to total net sales for the same period last year of $8.0 million and an

LITTLE ELM, Texas – Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00

LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.6 million for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the same period last year of $11.0 million

LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2023. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 29, 2024 with the U.S. Securities and

LITTLE ELM, Texas – Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00

You may have heard about the November 30, 2023 FDA Safety Communication, “Evaluating Plastic Syringes Made in China for Potential Device Failures.” Retractable Technologies Inc. wants to assure you that the safety communication does not refer or relate to VanishPoint safety syringes from Retractable Technologies. The FDA identified quality issues

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders LITTLE ELM, Texas – Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible